Chemoradiotherapy in anal cancer

Colorectal Disease

Volumn 13, Issue SUPPL. 1, 2011, Pages 33-38

  Kronfli, M ^a   Glynne Jones, R ^a  

^a MOUNT VERNON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL; MITOMYCIN;

ADJUVANT CHEMOTHERAPY; ANUS CANCER; ARTICLE; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CHEMORADIOTHERAPY; HUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIATION DOSE;

ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; ANUS NEOPLASMS; CISPLATIN; COMBINED MODALITY THERAPY; HUMANS; MITOMYCIN; RADIOTHERAPY; RADIOTHERAPY DOSAGE;

EID: 78751693615     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/j.1463-1318.2010.02497.x     Document Type: Article

References (25)

1. Nigro ND, Vaitkevicius VK, Considine B Jr. Combined therapy for cancer of the anal canal: a preliminary report. Dis Colon Rectum 1974; 17: 354-6.
2. Nigro ND. An evaluation of combined therapy for squamous call carcinoma of the anal canal. Dis Colon Rectum 1984; 27: 763-6.
3. Leichman L, Nigro N, Vaitkevicius VK et al. Cancer of the anal canal: model for preoperative adjuvant combined modality therapy. Am J Med 1985; 78: 211-5.
4. UKCCCR Anal Cancer Working Party. Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil and Mitomycin. Lancet 1996; 348: 1049-54.
5. Bartelink H, Roelofsen F, Eschwege F et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 1997; 15: 2040-9.
6. Flam M, John M, Pajak TF et al. Role of Mitomycin in combination with Fluorouracil and radiotherapy and of salvage chemoradiation in the definitive nonsurgical treatment of Epidermoid Carcinoma of the Anal Canal: results of a phase III randomized Intergroup Study. J Clin Oncol 1996; 14: 2527-39.
7. Ajani JA, Winter KA, Gunderson LL et al. Fluorouracil, Mitomycin and radiotherapy vs fluorouracil, cisplatin and radiotherapy for carcinoma of the anal canal: a randomised controlled trial. JAMA 2008; 199: 1914-21.
8. James R, Wan S, Glynne-Jones R et al. A randomised trial of chemoradiation using Mitomycin or cisplatin, with or without maintenance cisplatin/5FU in squamous cell carcinoma of the anus. J Clin Oncol 2009; (Proc ASCO) 27: 18S (part II of II); 797s (abstract LBA-4009)
9. Conroy T, Ducreux M, Lemanski C. Treatment intensification by induction chemotherapy (ICT) and radiation dose-escalation in locally advanced squamous cell anal canal carcinomaa (LAAC): definitive analysis of the intergroup ACCORD-03 trial. J Clin Oncol 2009; 27: 15s (Part I of II):176s (abstract 4033)
10. Slevin ML, Plowman PN, Ryan CM et al. Chemoradiotherapy for anal cancer improves quality of life compared to radiotherapy alone. J Clin Oncol 1998; 17 (abstract 266).
11. Schlienger M, Krzisch C, Pene F et al. Epidermoid carcinoma of the anal canal: treatment results and prognostic variables in a series of 242 cases. Int J Radiat Oncol Biol Phys 1989; 17: 1141-51.
12. Nigro ND, Seydel HG, Considine B Jr, Vaitkevicius VK, Leichman L, Kinzie JJ. Combined radiotherapy and chemotherapy for squamous cell carcinoma of the anal canal. Cancer 1983; 51: 1826-9.
13. Konski A, Garcia M, John M et al. Evaluation of planned treatment breaks during radiation therapy for anal cancer: update of RTOG 92-08. Int J Radiat Oncol Biol Phys 2008; 72: 114-8.
14. Eschwege F, Lasser P, Chavy A et al. Squamous cell carcinoma of the anal canal: treatment by external beam radiation. Radiother Oncol 1985; 4: 145-50.
15. Wong CS, Tsang RW, Cummings BJ et al. Proliferation parameters in epidermoid carcinomas of the anal canal. Radiother Oncol 2000; 56: 349-53.
16. Das P, Bhatia S, Eng C et al. Predictors and patterns of recurrence after definitive chemoradiation for anal cancer. Int J Radiat Oncol Biol Phys 2007; 68: 794-800.
17. Vuong T, Kopek N, Ducruet T et al. Conformal therapy improves the therapeutic index of patients with anal canal cancer treated with combined chemotherapy and external beam radiotherapy. Int J Radiat Oncol Biol Phys 2007; 67: 1394-400.
18. Salama JK, Mell LK, Schomas DA et al. Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience. J Clin Oncol 2007; 25: 4581-6.
19. Doci R, Zucali R, La Monica G et al. Primary chemoradiotherapy with fluouracil and cisplatin for cancer of the anus: results in 35 consecutive patients. J Clin Oncol 1996; 14: 3121-5.
20. Peiffert D, Bey P, Pernot M, Hoffstetter S, Marchal C, Beckendorf V, Guillemin F. Conservative treatment by irradiation of epidermoid carcinomas of the anal margin. Int J Radiat Oncol Biol Phys 1997; 39: 57-66.
21. Widder J, Kastenberger R, Fercher E et al. Radiation dose associated with local control in advanced anal cancer: retrospective analysis of 129 patients. Radiother Oncol 2008; 87: 367-75.
22. John M, Flam M, Palma N et al. Ten year results on chemoradiation for anal cancer: focus on late morbidity. Int J Radiat Oncol Biol Phys 1996; 34: 65-9.
23. Cummings BJ, Keane TJ, O'Sullivan B, Wong CS, Catton CN. Epidermoid anal cancer: treatment by radiation alone or by radiation and 5-fluorouracil with and without Mitomycin. Int J Radiat Oncol Biol Phys 1991; 21: 1115-25.
24. Matzinger O, Roelofsen F, Mineur L et al., for the EORTC Radiation Oncology and Gastrointestinal Tract Cancer Groups Mitomycin with continuous fluorouracil or with cisplatin in combination with radiotherapy for locally advanced anal cancer (European Organisation for Research and Treatment of Cancer phase II study 22011-40014). Eur J Cancer 2009; 45: 2782-91.
25. De Ruysscher D, Pijls-Johannes MM, Bentzen S et al. Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited-disease small-cell lung cancer. J Clin Oncol 2006; 24: 1053-63.